{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:31:06Z","timestamp":1790224266646,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013255","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000}}],"reference-count":367,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013255.pub2","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T07:03:40Z","timestamp":1717398220000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis"],"prefix":"10.1002","volume":"2024","author":[{"given":"Kishore","family":"Kukendrarajah","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Royal Free Hospital, Royal Free London NHS Foundation Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Carrington","sequence":"additional","affiliation":[{"name":"Cardiology; Hospital do Esp\u00edrito Santo de Evora; \u00c9vora Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Ioannou","sequence":"additional","affiliation":[{"name":"Royal Free London NHS Foundation Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Taylor","sequence":"additional","affiliation":[{"name":"Institute of Health Informatics Research; University College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuf","family":"Razvi","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Royal Free Hospital; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Papageorgiou","sequence":"additional","affiliation":[{"name":"Barts Heart Centre; St Bartholomew's Hospital, Barts Health NHS Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian E","family":"Mead","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences; University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculate F","family":"Nevis","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research; ICON plc; Blue Bell Philadelphia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"D'Ascenzo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine; University of Turin; Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B","family":"Wilton","sequence":"additional","affiliation":[{"name":"Libin Cardiovascular Institute; University of Calgary; Calgary Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier D","family":"Lambiase","sequence":"additional","affiliation":[{"name":"Centre for Cardiology in the Young; The Heart Hospital, University College London Hospitals; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A","family":"Morillo","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, Cumming School of Medicine; Foothills Medical Centre; Calgary Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey SW","family":"Kwong","sequence":"additional","affiliation":[{"name":"Global Health Nursing, Graduate School of Nursing Science; St. Luke's International University; Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Providencia","sequence":"additional","affiliation":[{"name":"Barts Heart Centre; St Bartholomew's Hospital, Barts Health NHS Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"issue":"4 Pt 1","key":"10.1002\/14651858.CD013255.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-8703(98)70010-9","article-title":"Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators","volume":"136","author":"Abi-Mansour","year":"1998","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"66A","DOI":"10.1016\/S0002-9149(97)89120-5","article-title":"Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation\/flutter","volume":"77","author":"Aliot","year":"1996","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0167-5273(00)00326-0","article-title":"Randomised comparison of antero-lateral versus antero-posterior paddle positions for DC cardioversion of persistent atrial fibrillation","volume":"75","author":"Alp","year":"2000","journal-title":"International Journal of Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD013255.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/oxfordjournals.eurheartj.a015146","article-title":"Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study","volume":"18","author":"Azpitarte","year":"1997","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0005|cit5","first-page":"600","article-title":"Pharmacological conversion of recent atrial fibrillation: a randomized study of three antiarrhythmic drugs","volume":"11","author":"Balla","year":"2011","journal-title":"Anadolu Kardiyol Derg"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0006|cit6","first-page":"600","article-title":"Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs","volume":"11","author":"Balla","year":"2011","journal-title":"Anadolu Kardiyol Derg"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00044011-199509050-00005","article-title":"A randomised study comparing digoxin and propafenone in the treatment of recent onset atrial fibrillation","volume":"9","author":"Baroffio","year":"1995","journal-title":"Clinical Drug Investigation"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0008|cit8","first-page":"350","article-title":"Quinidine for pharmacological cardioversion of long-lasting atrial fibrillation","volume":"4","author":"Baroni","year":"2011","journal-title":"Journal of Atrial Fibrillation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12872-016-0289-0","article-title":"Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm: a phase 3b randomized controlled trial","volume":"16","author":"Beatch","year":"2016","journal-title":"BMC Cardiovascular Disorders"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/FJC.0000000000000445","article-title":"Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation in the Asia-Pacific region: a phase 3 randomized controlled trial","volume":"69","author":"Beatch","year":"2017","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/clc.4960181108","article-title":"Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: a placebo-controlled study","volume":"18","author":"Bellandi","year":"1995","journal-title":"Clinical Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00823593","article-title":"Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation - a single-blind placebo-controlled study","volume":"10","author":"Bellandi","year":"1996","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/emj.2010.109702","article-title":"Cardioversion of acute atrial fibrillation in the emergency department: a prospective randomised trial","volume":"29","author":"Bellone","year":"2012","journal-title":"Emergency Medicine Journal"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0736-4679(90)90380-E","article-title":"Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmias","volume":"8","author":"Bertini","year":"1990","journal-title":"Journal of Emergency Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0002-9149(98)00412-3","article-title":"Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. The Propafenone in Atrial Fibrillation Italian Trial","volume":"82","author":"Bianconi","year":"1998","journal-title":"American Journal of Cardiology"},{"issue":"15","key":"10.1002\/14651858.CD013255.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1053\/euhj.1999.2039","article-title":"Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study","volume":"21","author":"Bianconi","year":"2000","journal-title":"European Heart Journal"},{"issue":"9","key":"10.1002\/14651858.CD013255.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0002-9149(99)00493-2","article-title":"Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation","volume":"84","author":"Blanc","year":"1999","journal-title":"American Journal of Cardiology"},{"issue":"11 Pt 2","key":"10.1002\/14651858.CD013255.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/j.1540-8159.1998.tb01202.x","article-title":"Oral loading with propafenone: a placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation","volume":"21","author":"Boriani","year":"1998","journal-title":"Pacing & Clinical Electrophysiology"},{"issue":"8","key":"10.1002\/14651858.CD013255.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-126-8-199704150-00006","article-title":"Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial","volume":"126","author":"Boriani","year":"1997","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/hrt.82.6.726","article-title":"External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements","volume":"82","author":"Botto","year":"1999","journal-title":"Heart"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/acem.13522","article-title":"Low-dose magnesium sulfate versus high dose in the early management of rapid atrial fibrillation: randomized controlled double-blind study (LOMAGHI study)","volume":"26","author":"Bouida","year":"2019","journal-title":"Academic Emergency Medicine"},{"issue":"12","key":"10.1002\/14651858.CD013255.pub2-BIB0022|cit22","first-page":"994","article-title":"Anterior-posterior versus anterior-lateral electrode position for biphasic cardioversion of atrial fibrillation","volume":"42","author":"Brazdzionyte","year":"2006","journal-title":"Medicina (Kaunas)"},{"issue":"16","key":"10.1002\/14651858.CD013255.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0002-9149(94)90190-2","article-title":"Magnesium therapy in new-onset atrial fibrillation","volume":"73","author":"Brodsky","year":"1994","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jacc.2010.07.046","article-title":"A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation","volume":"57","author":"Camm","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/europace\/eur416","article-title":"Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ehj.2003.10.020","article-title":"A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation","volume":"25","author":"Channer","year":"2004","journal-title":"European Heart Journal"},{"issue":"2-3","key":"10.1002\/14651858.CD013255.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0167-5273(01)00450-8","article-title":"Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation","volume":"79","author":"Chiladakis","year":"2001","journal-title":"International Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1553-2712.2009.00360.x","article-title":"Magnesium sulfate versus placebo for paroxysmal atrial fibrillation: a randomized clinical trial","volume":"16","author":"Chu","year":"2009","journal-title":"Academic Emergency Medicine"},{"issue":"24","key":"10.1002\/14651858.CD013255.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1053\/euhj.1999.1747","article-title":"Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study","volume":"20","author":"Cotter","year":"1999","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"329\u201335","DOI":"10.1002\/clc.4950260707","article-title":"Intravenous amiodarone for cardioversion of recent-onset atrial fbrillation","volume":"26","author":"Cybulski","year":"2003","journal-title":"Clinical Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.annemergmed.2004.09.013","article-title":"A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation","volume":"45","author":"Davey","year":"2005","journal-title":"Annals of Emergency Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0735-1097(96)00121-0","article-title":"Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study","volume":"28","author":"Ellenbogen","year":"1996","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0033|cit33","first-page":"406","article-title":"Efficacy of intravenous propafenone in converting atrial fibrillation and flutter in sinus rhythm","volume":"25","author":"Fak","year":"1997","journal-title":"Turk Kardiyoloji Dernegi Arsivi [Turkish]"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/107424849700200403","article-title":"Intravenous propafenone for conversion of atrial fibrillation or flutter to sinus rhythm: a randomized, placebo-controlled, crossover study","volume":"2","author":"Fak","year":"1997","journal-title":"Journal of Cardiovascular Pharmacological Therapy"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0735-1097(96)00506-2","article-title":"Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators","volume":"29","author":"Falk","year":"1997","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/clc.4960190515","article-title":"Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial","volume":"19","author":"Fresco","year":"1996","journal-title":"Clinical Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/107424840100600403","article-title":"Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: a prospective, multicenter, randomized, controlled, double blind trial","volume":"6","author":"Galperin","year":"2001","journal-title":"Journal of Cardiovascular Pharmacological Therapy"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0736-4679(98)00003-1","article-title":"Intravenous propafenone for converting recent onset atrial fibrillation in emergency departments: a randomized placebo-controlled multicenter trial","volume":"16","author":"Ganau","year":"1998","journal-title":"Journal of Emergency Medicine"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0002-9149(99)80137-4","article-title":"Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial)","volume":"76","author":"Halinen","year":"1995","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0040|cit40","first-page":"13","article-title":"Effectivity and safety of sotalol verses chinidin in the conversion therapy of persistent atrial fibrillation: a prospective randomised comparison","volume":"83 Suppl 1","author":"Hohnloser","year":"1994","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0735-1097(95)00286-5","article-title":"Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine","volume":"26","author":"Hohnloser","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0300-9572(90)90083-Q","article-title":"Comparison of two different electrodes for the delivery of DC-shocks","volume":"20","author":"Jakobsson","year":"1990","journal-title":"Resuscitation"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mem.2000.107655","article-title":"A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation","volume":"36","author":"Joseph","year":"2000","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.amjcard.2004.05.037","article-title":"Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation","volume":"94","author":"Kanoupakis","year":"2004","journal-title":"American Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD013255.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1540-8167.2003.03133.x","article-title":"Biphasic versus monophasic cardioversion in shock-resistant atrial fibrillation","volume":"14","author":"Khaykin","year":"2003","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.amjcard.2004.07.149","article-title":"Comparison of rectilinear biphasic waveform energy versus truncated exponential biphasic waveform energy for transthoracic cardioversion of atrial fibrillation","volume":"94","author":"Kim","year":"2004","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"138A","DOI":"10.1016\/S0735-1097(03)80813-6","article-title":"Prospective randomized comparison of rectilinear biphasic waveform shock versus truncated exponential biphasic waveform shock for transthoracic cardioversion of atrial fibrillation","volume":"41","author":"Kim","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"issue":"13","key":"10.1002\/14651858.CD013255.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/eurheartj\/ehi160","article-title":"A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA)","volume":"26","author":"Kirchhof","year":"2005","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1007714203984","article-title":"Conversion of atrial fibrillation to sinus rhythm using acute intravenous procainamide infusion","volume":"12","author":"Kochiadakis","year":"1998","journal-title":"Cardiovascular Drugs Therapy"},{"issue":"11 Pt 2","key":"10.1002\/14651858.CD013255.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1111\/j.1540-8159.1998.tb01204.x","article-title":"Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study","volume":"21","author":"Kochiadakis","year":"1998","journal-title":"Pacing & Clinical Electrophysiology"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0002-9149(98)00783-8","article-title":"Efficacy of amiodarone for the termination of persistent atrial fibrillation","volume":"83","author":"Kochiadakis","year":"1999","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0735-1097(98)00678-0","article-title":"Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study","volume":"33","author":"Kochiadakis","year":"1999","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD013255.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.amjcard.2007.01.059","article-title":"A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation","volume":"99","author":"Kochiadakis","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0054|cit54","first-page":"360","article-title":"Efficacy and safety of oral propafenone versus quinidine in restoring sinus rhythm in patients with an attack of atrial fibrillation - a prospective randomized study","volume":"4","author":"Kosior","year":"2009","journal-title":"Folia Cardiologica Excerpta"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0055|cit55","first-page":"521","article-title":"Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: a randomized, prospective study","volume":"16","author":"Kosior","year":"2009","journal-title":"Cardiology Journal"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.ahj.2003.10.049","article-title":"A randomized trial comparing monophasic and biphasic waveform shocks for external cardioversion of atrial fibrillation","volume":"147","author":"Koster","year":"2004","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0167-5273(91)90269-U","article-title":"Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation","volume":"31","author":"Kuhlkamp","year":"1991","journal-title":"International Journal of Cardiology"},{"issue":"11 Pt 2","key":"10.1002\/14651858.CD013255.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1111\/j.1540-8159.2000.tb07043.x","article-title":"Single oral administration of pilsicainide versus infusion of disopyramide for termination of paroxysmal atrial fibrillation: a multicenter trial","volume":"23","author":"Kumagai","year":"2000","journal-title":"Pacing & Clinical Electrophysiology"},{"issue":"8","key":"10.1002\/14651858.CD013255.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0002-9149(99)00927-3","article-title":"Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter","volume":"85","author":"Lindeboom","year":"2000","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0060|cit60","first-page":"906","article-title":"Clinical efficacy of antazoline in rapid cardioversion of paroxysmal atrial fibrillation: a single centre, randomized, double blind, placebo controlled study","volume":"Suppl 1","author":"Farkowski","journal-title":"European Heart Journal"},{"issue":"10","key":"10.1002\/14651858.CD013255.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/europace\/euw384","article-title":"Efficacy and safety of antazoline in the rapid cardioversion of paroxysmal atrial fibrillation (the AnPAF study)","volume":"19","author":"Maciag","year":"2017","journal-title":"Europace"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013255.pub2-BIB0062|cit62","first-page":"43","article-title":"Flecainide versus procainamide in the treatment of paroxystic atrial fibrillation","volume":"45","author":"Madrid","year":"1992","journal-title":"Revista Espanola de Cardiologia"},{"issue":"8","key":"10.1002\/14651858.CD013255.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/eurheartj\/14.8.1127","article-title":"Comparison of flecainide and procainamide in cardioversion of atrial fibrillation","volume":"14","author":"Madrid","year":"1993","journal-title":"European Heart Journal"},{"issue":"14","key":"10.1002\/14651858.CD013255.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/eurheartj\/ehm211","article-title":"External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application","volume":"28","author":"Manegold","year":"2007","journal-title":"European Heart Journal"},{"issue":"9","key":"10.1002\/14651858.CD013255.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0002-9149(00)01128-0","article-title":"Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm","volume":"86","author":"Martinez-Marcos","year":"2000","journal-title":"American Journal of Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD013255.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/clc.4960211013","article-title":"Propafenone versus procainamide for conversion of atrial fibrillation to sinus rhythm","volume":"21","author":"Mattioli","year":"1998","journal-title":"Clinical Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.CIR.101.11.1282","article-title":"Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks","volume":"101","author":"Mittal","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000113429","article-title":"Biphasic versus monophasic shock for external cardioversion of atrial flutter: a prospective, randomized trial","volume":"111","author":"Mortensen","year":"2008","journal-title":"Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0069|cit69","first-page":"222A","article-title":"Atrial flutter: Is biphasic superior to monophasic external cardioversion? A randomized comparison","volume":"45","author":"Risius","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0070|cit70","first-page":"225","article-title":"[Electrode position in elective electrical cardioversion of atrial fibrillation. A randomized study]","volume":"34","author":"Munoz-Martinez","year":"2010","journal-title":"Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0011-393X(05)80319-4","article-title":"A comparison of propafenone and amiodarone in reversion of recent-onset atrial fibrillation to sinus rhythm","volume":"55","author":"Negrini","year":"1994","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00392-004-0061-9","article-title":"[Ambulatory electrocardioversion of atrial fibrillation by means of biphasic versus monophasic shock delivery. A prospective randomized study]","volume":"93","author":"Neumann","year":"2004","journal-title":"Zeitschrift fu\u0308r Kardiologie"},{"issue":"9","key":"10.1002\/14651858.CD013255.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0002-9149(90)91053-9","article-title":"Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm","volume":"65","author":"Noc","year":"1990","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0074|cit74","first-page":"800","article-title":"Magnesium in the management of atrial fibrillation with rapid ventricular response","volume":"8","author":"Nogic","year":"2022","journal-title":"Journal of the American College: Clinical Electrophysiology"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-8703(99)70363-7","article-title":"Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"137","author":"Norgaard","year":"1999","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1067\/mhj.2000.107174","article-title":"Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study","volume":"140","author":"Okishige","year":"2000","journal-title":"American Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1253\/circj.70.657","article-title":"Pharmacological conversion of persistent atrial fibrillation into sinus rhythm with oral pilsicainide: pilsicainide suppression trial for persistent atrial fibrillation II","volume":"70","author":"Kumagai","year":"2006","journal-title":"Circulation Journal"},{"issue":"12","key":"10.1002\/14651858.CD013255.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/S0735-1097(02)01898-3","article-title":"Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial","volume":"39","author":"Page","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD013255.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.amjcard.2010.06.054","article-title":"Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation","volume":"106","author":"Pratt","year":"2010","journal-title":"American Journal of Cardiology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013255.pub2-BIB0080|cit80","article-title":"Efficacy of intravenous magnesium for cardioversion of atrial fibrillation","volume":"130","author":"Rajagopalan","year":"2014","journal-title":"Circulation. Conference: American Heart Association"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"e003968","DOI":"10.1161\/CIRCEP.116.003968","article-title":"Efficacy of intravenous magnesium in facilitating cardioversion of atrial fibrillation","volume":"9","author":"Rajagopalan","year":"2016","journal-title":"Circulation. Arrhythmia & Electrophysiology"},{"issue":"12","key":"10.1002\/14651858.CD013255.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0002-9149(98)00223-9","article-title":"Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation","volume":"81","author":"Reisinger","year":"1998","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0083|cit83","first-page":"390","article-title":"Comparison between flecainid and sotalol in the conversion treatment of atrial fibrillation","volume":"87","author":"Reisinger","year":"1998","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"15","key":"10.1002\/14651858.CD013255.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ehj.2004.04.030","article-title":"Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset","volume":"25","author":"Reisinger","year":"2004","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/eupc.2001.0156","article-title":"External cardioversion of atrial fibrillation: comparison of biphasic vs monophasic waveform shocks","volume":"3","author":"Ricard","year":"2001","journal-title":"Europace"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.amjcard.2009.07.027","article-title":"Comparison of antero-lateral versus antero-posterior electrode position for biphasic external cardioversion of atrial flutter","volume":"104","author":"Risius","year":"2009","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0087|cit87","first-page":"41","article-title":"[Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation]","volume":"2","author":"Romano","year":"2001","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013255.pub2-BIB0088|cit88","first-page":"58","article-title":"Propafenone and e.v. flecainide in paroxysmal atrial fibrillation","volume":"27","author":"Romano","year":"1997","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013255.pub2-BIB0089|cit89","first-page":"445","article-title":"Propafenone or flecainide e.v. in atrial paroxistic fibrillation","volume":"25","author":"Romano","year":"1995","journal-title":"Giornale Italiano di Cardiologia"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0090|cit90","first-page":"4","article-title":"Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial","volume":"14","author":"Harris","year":"2013","journal-title":"Congestive Heart Failure"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2004.09.021","article-title":"A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation","volume":"44","author":"Roy","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD013255.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.107.723866","article-title":"Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial","volume":"117","author":"Roy","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0093|cit93","first-page":"141","article-title":"[A comparison between propafenone and hydroquinidine perorally in the treatment of recent-onset atrial fibrillation]","volume":"44","author":"Satullo","year":"1996","journal-title":"Minerva Cardioangiologica"},{"issue":"S1","key":"10.1002\/14651858.CD013255.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1017\/cem.2016.137","article-title":"LO100: Electrical vs chemical cardioversion in patients with acute atrial fibrillation: a multicenter parallel group randomized controlled clinical trial","volume":"18","author":"Scheuermeyer","year":"2016","journal-title":"Canadian Journal of Emergency Medicine"},{"issue":"9","key":"10.1002\/14651858.CD013255.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/acem.13669","article-title":"A multicenter randomized trial to evaluate a chemical-first or electrical-first cardioversion strategy for patients with uncomplicated acute atrial fibrillation","volume":"26","author":"Scheuermeyer","year":"2019","journal-title":"Academic Emergency Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"08","DOI":"10.1161\/JAHA.116.004853","article-title":"Cardioversion efficacy using pulsed biphasic or biphasic truncated exponential waveforms: a randomized clinical trial","volume":"6","author":"Schmidt","year":"2017","journal-title":"Journal of the American Heart Association"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/eurheartj\/ehz627","article-title":"Comparison of high versus escalating shocks in cardioverting atrial fibrillation","volume":"41","author":"Schmidt","year":"2019","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1161\/CIRCULATIONAHA.121.056301","article-title":"Anterior\u2013lateral versus anterior\u2013posterior electrode position for cardioverting atrial fibrillation","volume":"144","author":"Schmidt","year":"2021","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1046\/j.1540-8167.2004.04027.x","article-title":"Impact of biphasic electrical cardioversion of atrial fibrillation on early recurrent atrial fibrillation and shock efficacy","volume":"15","author":"Siaplaouras","year":"2004","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ahj.2004.08.009","article-title":"Randomized comparison of anterolateral versus anteroposterior electrode position for biphasic external cardioversion of atrial fibrillation","volume":"150","author":"Siaplaouras","year":"2005","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0101|cit101","first-page":"132","article-title":"Vernakalant shows superiority to ibutilide in recent-onset atrial fibrillation: a randomized controlled trial at the emergency department","volume":"Suppl 3","author":"Simon","year":"2015","journal-title":"Circulation. Conference: American Heart Association"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0102|cit102","first-page":"233","article-title":"Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department","volume":"19","author":"Simon","year":"2017","journal-title":"Europace"},{"issue":"19","key":"10.1002\/14651858.CD013255.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"issue":"17","key":"10.1002\/14651858.CD013255.pub2-BIB0104|cit104","first-page":"508","article-title":"Efficacy of sotalol, amiodarone and placebo for cardioversion and maintenance of sinus rhythm in patients with atrial fibrillation: a Veterans Administration cooperative study","volume":"108","author":"Singh","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1056\/NEJMoa041705.","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/s0002-9149(03)00671-4","article-title":"Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])","volume":"92","author":"Singh","year":"2003","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.hrthm.2008.10.036","article-title":"Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial","volume":"6","author":"Singh","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.hrthm.2020.11.005","article-title":"Active compression versus standard anterior-posterior defibrillation for external cardioversion of atrial fibrillation: a prospective randomized study","volume":"18","author":"Squara","year":"2021","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.94.7.1613","article-title":"Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation","volume":"94","author":"Stambler","year":"1996","journal-title":"Circulation"},{"issue":"9","key":"10.1002\/14651858.CD013255.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/medicina44090085","article-title":"[Impact of electrical shock waveform and paddle positions on efficacy of direct current cardioversion for atrial fibrillation]","volume":"44","author":"Stanaitiene","year":"2008","journal-title":"Medicina (Kaunas)"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0111|cit111","first-page":"67","article-title":"Low energy electrical cardioversion of atrial fibrillation","volume":"1","author":"Stanaitiene","year":"2009","journal-title":"Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9149(96)00779-5","article-title":"Propafenone for conversion and prophylaxis of atrial fibrillation","volume":"79","author":"Stroobandt","year":"1997","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10557-005-6898-y","article-title":"Clinical comparison of ibutilide and propafenone for converting atrial flutter","volume":"19","author":"Sun","year":"2005","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0002-9149(89)90253-1","article-title":"Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm","volume":"63","author":"Suttorp","year":"1989","journal-title":"American Journal of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/0735-1097(90)90326-K","article-title":"The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm","volume":"16","author":"Suttorp","year":"1990","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ihj.2022.04.006","article-title":"Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: a randomized controlled comparative study","volume":"17","author":"Taha","year":"2022","journal-title":"Indian Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1016\/S0002-8703(03)00526-X","article-title":"Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial","volume":"147","author":"Thomas","year":"2004","journal-title":"American Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0118|cit118","first-page":"293","article-title":"[A comparison between propafenone and amiodarone in the conversion to sinus rhythm of atrial fibrillation of recent onset]","volume":"42","author":"Treglia","year":"1994","journal-title":"Minerva Cardioangiologica"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3390\/diagnostics11061107","article-title":"A randomized comparison of delivered energy in cardioversion of atrial fibrillation: biphasic truncated exponential versus pulsed biphasic waveforms","volume":"11","author":"Trendafilova","year":"2021","journal-title":"Diagnostics"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1378\/chest.117.6.1538","article-title":"Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study","volume":"117","author":"Vardas","year":"2000","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0121|cit121","first-page":"A40","article-title":"Randomised trial of two anti-arrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom DC cardioversion is planned","volume":"89","author":"Vijayalakshmi","year":"2003","journal-title":"Heart"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"863.e1","DOI":"10.1016\/j.ahj.2005.09.009","article-title":"A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned","volume":"151","author":"Vijayalakshmi","year":"2006","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.ijcard.2008.05.038","article-title":"External cardioversion of atrial fibrillation: the role of electrode position on cardioversion success","volume":"137","author":"Vogiatzis","year":"2009","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0124|cit124","first-page":"67","article-title":"Vernakalant versus ibutilide for immediate conversion of recent-onset atrial fibrillation","volume":"21","author":"Vogiatzis","year":"2017","journal-title":"Hippokratia"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0735-1097(98)00078-3","article-title":"Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation","volume":"31","author":"Volgman","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/hrt.79.6.568","article-title":"Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation","volume":"79","author":"Vos","year":"1998","journal-title":"Heart"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0127|cit127","doi-asserted-by":"crossref","unstructured":"Voskoboinik A Moskovitch J Bloom J Nalliah CJ Prabhu S Wong G Hand-held paddles more effective than adhesive patches for cardioversion of atrial fibrillation in obese patients: results from the DCR-BMI multicenter randomized controlled trial Heart Rhythm 2018 15 5 Supplement 1 S261 2","DOI":"10.1016\/j.hlc.2018.06.275"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jce.13786","article-title":"Cardioversion of atrial fibrillation in obese patients: results from the Cardioversion-BMI randomized controlled trial","volume":"30","author":"Voskoboinik","year":"2019","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"13","key":"10.1002\/14651858.CD013255.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/eurheartj\/ehi196","article-title":"Impedance compensated biphasic waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre comparison of antero-apical and antero-posterior pad positions","volume":"26","author":"Walsh","year":"2005","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0130|cit130","first-page":"433","article-title":"Comparative study of intravenous amiodarone and procainamide in the treatment of atrial fibrillation of recent onset","volume":"55","author":"Xanthos","year":"2007","journal-title":"Minerva Cardioangiologica"},{"issue":"14","key":"10.1002\/14651858.CD013255.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/heartjnl-2012-302017","article-title":"Effectiveness of amiodarone versus bepridil in achieving conversion to sinus rhythm in patients with persistent atrial fibrillation: a randomised trial","volume":"98","author":"Yamase","year":"2012","journal-title":"Heart"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0132|cit132","first-page":"331","article-title":"Conversion to sinus rhythm: efficacy of amiodarone vs bepridil for persistent atrial fibrillation","volume":"33","author":"Yamase","year":"2012","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1253\/circj.CJ-08-1061","article-title":"Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled,double-blind study (J-BAF Study)","volume":"73","author":"Yamashita","year":"2009","journal-title":"Circulation Journal"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0134|cit134","first-page":"212","article-title":"[Efficacy and safety of ibutilide for conversion of atrial fibrillation\/flutter]","volume":"42","author":"Yu","year":"2013","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD013255.pub2-BIB0135|cit135","first-page":"101","article-title":"Amiodaron and verapamil\/chinidin in the treatment of patients with chronic atrial fibrillation [German]","volume":"83","author":"Zehender","year":"1994","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"12","key":"10.1002\/14651858.CD013255.pub2-BIB0136|cit136","first-page":"798","article-title":"[Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study]","volume":"85","author":"Zhang","year":"2005","journal-title":"Chung Hua I Hsueh Tsa Chih"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1253\/circj.CJ-09-0367","article-title":"Comparison of antiarrhythmics used in patients with paroxysmal atrial fibrillation: subanalysis of J-RHYTHM study","volume":"74","author":"Aizawa","year":"2010","journal-title":"Circulation Journal"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"e12508","DOI":"10.1111\/anec.12508","article-title":"Efficacy and safety of intravenous vernakalant for the rapid conversion of recent-onset atrial fibrillation: a meta-analysis","volume":"23","author":"Akel","year":"2018","journal-title":"Annals of Noninvasive Electrocardiology"},{"issue":"23","key":"10.1002\/14651858.CD013255.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","article-title":"Outpatient treatment of recent-onset atrial fibrillation with the \"pill-in-the-pocket\" approach","volume":"351","author":"Alboni","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1378\/chest.117.6.1529","article-title":"Medical cardioversion of atrial fibrillation","volume":"117","author":"Alpert","year":"2000","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0141|cit141","first-page":"400","article-title":"What about magnesium sulfate in atrial fibrillation with acute heart failure?","volume":"1)","author":"Benhalla","year":"2015","journal-title":"European Journal of Heart Failure"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9149(86)90022-6","article-title":"Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm","volume":"58","author":"Borgeat","year":"1986","journal-title":"American Journal of Cardiology"},{"issue":"11 Pt 2","key":"10.1002\/14651858.CD013255.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1111\/j.1540-8159.1998.tb01203.x","article-title":"Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols","volume":"21","author":"Boriani","year":"1998","journal-title":"Pacing & Clinical Electrophysiology"},{"issue":"11 Pt 2","key":"10.1002\/14651858.CD013255.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/j.1540-8159.1996.tb03257.x","article-title":"Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary?","volume":"19","author":"Botto","year":"1996","journal-title":"Pacing & Clinical Electrophysiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"A12420","DOI":"10.1161\/circ.146.suppl_1.12420","article-title":"Orally inhaled flecainide for the conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm: final results from the phase 2 instant trial","volume":"146","author":"Camm","year":"2022","journal-title":"Circulation"},{"issue":"Suppl","key":"10.1002\/14651858.CD013255.pub2-BIB0146|cit146","first-page":"ii16","article-title":"Comparing the efficacy, hospitalization time and safety of vernakalant to propafenone in recent-onset atrial fibrillation in the emergency department","volume":"2","author":"Aragon","year":"2013","journal-title":"Europace"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/1755-5922.12036","article-title":"Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation","volume":"31","author":"Conde","year":"2013","journal-title":"Cardiovascular Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD013255.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/oxfordjournals.eurheartj.a060402","article-title":"Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug","volume":"15","author":"Crijns","year":"1994","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0149|cit149","unstructured":"An open-label, multicentre, prospective, phase-IV study to evaluate the efficacy and safety of ibutilide fumarate injection (0.1 mg\/mL) in the treatment of atrial fibrillation and flutter - IBUTILIDE PHASE IV https:\/\/www.ctri.nic.in\/Clinicaltrials\/showallp.php?mid1=20124&EncHid=&userName=CTRI\/2018\/01\/011248"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000151703","article-title":"Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management","volume":"112","author":"Dankner","year":"2009","journal-title":"Cardiology"},{"issue":"23","key":"10.1002\/14651858.CD013255.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/01.CIR.98.23.2574","article-title":"Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT)","volume":"98","author":"Deedwania","year":"1998","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.hrthm.2015.02.014","article-title":"COR-ART: a multicenter, randomized, double-blind, placebo-controlled dose-ranging study to evaluate single oral doses of vanoxerine for conversion of recent-onset atrial fibrillation or flutter to normal sinus rhythm","volume":"12","author":"Dittrich","year":"2015","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1002\/14651858.CD013255.pub2-BIB0153|cit153","first-page":"201","article-title":"Increased efficacy of ajmaline after magnesium administration in the treatment of paroxysmal supraventricular tachyarrhythmias [Polish]","volume":"41","author":"Dluzniewski","year":"1994","journal-title":"Kardiologia Polska"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"50A","DOI":"10.1016\/0002-9149(92)91078-i","article-title":"Efficacy of flecainide for the reversion of acute onset atrial fibrillation","volume":"70","author":"Donovan","year":"1992","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-9149(91)90435-N","article-title":"Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide","volume":"67","author":"Donovan","year":"1991","journal-title":"American Journal of Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD013255.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-9149(99)80655-9","article-title":"Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation","volume":"75","author":"Donovan","year":"1995","journal-title":"American Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0157|cit157","first-page":"982","article-title":"Is either sotalol or amiodarone more effective than digoxin for converting patients with new-onset atrial fibrillation (AF) to sinus rhythm within 48 hours?","volume":"49","author":"Forney","year":"2000","journal-title":"Journal of Family Practice"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0735-1097(95)00595-1","article-title":"Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study","volume":"27","author":"Galve","year":"1996","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/clc.4960160512","article-title":"The effect of magnesium versus verapamil on supraventricular arrhythmias","volume":"16","author":"Gullestad","year":"1993","journal-title":"Clinical Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0735-1097(95)00607-9","article-title":"Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability","volume":"27","author":"Guo","year":"1996","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0161|cit161","first-page":"49","article-title":"[Comparative study of the efficacy and tolerability of 2 modalities of intravenous cibenzoline administration in the reduction of recent spontaneous atrial arrhythmia]","volume":"44","author":"Hermida","year":"1995","journal-title":"Annales de Cardiologie Angeiologie (Paris)"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jacc.2004.03.047","article-title":"Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter","volume":"44","author":"Hohnloser","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.eurheartj.a060945","article-title":"Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study","volume":"16","author":"Hou","year":"1995","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0164|cit164","first-page":"95-7","article-title":"Comparison of the efficacy and safety of intravenous esmolol and deslanoside in decreasing heart rate of patients with rapid atrial fibrillation","volume":"26","author":"Huang","year":"2003","journal-title":"Journal of Binzhou Medical College"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0002-9149(98)00294-X","article-title":"Effect of intravenous procainamide on direct-current cardioversion of atrial fibrillation","volume":"82","author":"Jacobs","year":"1998","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2006.07.017","article-title":"Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter","volume":"118","author":"Kafkas","year":"2007","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1022367311529","article-title":"Pharmacological cardioversion of recent onset atrial fibrillation with intravenous amiodarone in patients receiving long-term amiodarone therapy: is it reasonable?","volume":"8","author":"Kanoupakis","year":"2003","journal-title":"Journal of Interventional Cardiology & Electrophysiology"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/j.1875-9114.1997.tb03693.x","article-title":"Pharmacologic conversion of atrial fibrillation and atrial flutter to normal sinus rhythm: the role of ibutilide","volume":"17","author":"Katcher","year":"1997","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.1996.00440010061008","article-title":"The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation","volume":"156","author":"Kerin","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"56A","DOI":"10.1016\/0002-9149(92)91079-J","article-title":"Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil","volume":"70","author":"Kingma","year":"1992","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0171|cit171","doi-asserted-by":"publisher","first-page":"A56","DOI":"10.1016\/0002-9149(92)91079-j","article-title":"Acute pharmacological conversion of atrial fibrillation and flutter - the role of flecainide, propafenone, and verapamil","volume":"70","author":"Kingma","year":"1992","journal-title":"American Journal of Cardiology"},{"issue":"9342","key":"10.1002\/14651858.CD013255.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(02)11315-8","article-title":"Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial","volume":"360","author":"Kirchhof","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD013255.pub2-BIB0173|cit173","first-page":"481","article-title":"Fourier transformation analysis of atrial fibrillation intervals following ibutilide and procainamide to predict successful cardioversion","volume":"29","author":"Kirilmaz","year":"2001","journal-title":"Turk Kardiyoloji Dernegi Arsivi"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0174|cit174","first-page":"652","article-title":"Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery a randomized, double-blind, placebo-controlled trial","volume":"2","author":"Kowey","year":"2009","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000169654","article-title":"Double-blind evaluation of practolol and quinidine in the treatment of chronic atrial fibrillation","volume":"58","author":"Levi","year":"1973","journal-title":"Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1067\/mhj.2000.106169","article-title":"High-dose bolus lidocaine for chemical cardioversion of atrial fibrillation: a prospective, randomized, double-blind crossover trial","volume":"139","author":"Marrouche","year":"2000","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0177|cit177","first-page":"49","article-title":"[Verapamil in the cardioversion of atrial fibrillation. Clinical study]","volume":"51","author":"Martinelli","year":"2003","journal-title":"Minerva Cardioangiologia"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0178|cit178","first-page":"202","article-title":"[Comparison of lidoflazine and quinidine in the conversion to sinusal rhythm in atrial fibrillation of recent onset]","volume":"20","author":"Masini","year":"1990","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/hrt.81.6.576","article-title":"Randomised comparison of electrode positions for cardioversion of atrial fibrillation","volume":"81","author":"Mathew","year":"1999","journal-title":"Heart"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0180|cit180","first-page":"S216","article-title":"A comparison of intravenous rate control agents for new onset atrial fibrillation with rapid ventricular rate","volume":"1","author":"Mieure","year":"2011","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1002\/14651858.CD013255.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0735-1097(19)30906-4","article-title":"Safety and effectiveness of pharmacological conversion and direct current cardioversion in persistent atrial fibrillation: results of randomized trial","volume":"73","author":"Mironov","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"664","DOI":"10.20996\/1819-6446-2018-14-5-664-669","article-title":"Safety and effectiveness of electrical and pharmacological cardioversion in persistent atrial fibrillation. Part I: Study rationale, design and assessment of effectiveness [Russian]","volume":"14","author":"Mironov","year":"2018","journal-title":"Rational Pharmacotherapy in Cardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0183|cit183","first-page":"618","article-title":"Effect of dronedarone in patients with permanent atrial fibrillation during the ATHENA study","volume":"1","author":"Nieuwlaat","year":"2011","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1253\/circj.CJ-08-1139","article-title":"Predicting the efficacy of antiarrhythmic agents for interrupting persistent atrial fibrillation according to spectral analysis of the fibrillation waves on the surface ECG","volume":"73","author":"Niwano","year":"2009","journal-title":"Circulation Journal"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0002-9149(99)00241-6","article-title":"Effect of electrode polarity on the energy required for transthoracic atrial defibrillation","volume":"84","author":"Oral","year":"1999","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.104.3.292","article-title":"Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (Diamond) substudy","volume":"104","author":"Pedersen","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0002-9149(99)00789-4","article-title":"Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation","volume":"85","author":"Peuhkurinen","year":"2000","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0188|cit188","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMoa1900353","article-title":"Early or delayed cardioversion in recent-onset atrial fibrillation","volume":"380","author":"Pluymaekers","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0189|cit189","first-page":"114","article-title":"Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation","volume":"8","author":"Pohjantahti-Maaroos","year":"2019","journal-title":"European Heart Journal of Acute Cardiovascular Care"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1067\/mhj.2002.120155","article-title":"Effect of shock polarity on the efficacy of transthoracic atrial defibrillation","volume":"143","author":"Rashba","year":"2002","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1023\/B:CEPR.0000012398.01150.eb","article-title":"Biphasic versus monophasic shock waveform for conversion of atrial fibrillation","volume":"7","author":"Rho","year":"2003","journal-title":"Cardiac Electrophysiology Review"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebcm.2003.12.032","article-title":"Trial finds sustained release propafenone increases time to recurrent atrial fibrillation compared with placebo","volume":"8","year":"2004","journal-title":"Evidence-based Cardiovascular Medicine"},{"issue":"12","key":"10.1002\/14651858.CD013255.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1161\/01.CIR.96.12.4298","article-title":"Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy","volume":"96","author":"Stambler","year":"1997","journal-title":"Circulation"},{"issue":"S1","key":"10.1002\/14651858.CD013255.pub2-BIB0194|cit194","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1017\/cem.2019.41","article-title":"PL02: A randomized, controlled comparison of electrical versus pharmacological cardioversion for emergency department patients with recent-onset atrial fibrillation","volume":"21","author":"Stiell","year":"2019","journal-title":"Canadian Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1017\/cem.2020.64","article-title":"A randomized, controlled comparison of electrical versus pharmacological cardioversion for emergency department patients with atrial flutter","volume":"22","author":"Stiell","year":"2020","journal-title":"Canadian Journal of Emergency Medicine"},{"issue":"10221","key":"10.1002\/14651858.CD013255.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(19)32994-0","article-title":"Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial","volume":"395","author":"Stiell","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.cjca.2021.08.018","article-title":"Adverse events associated with electrical cardioversion in patients with acute atrial fibrillation and atrial flutter","volume":"37","author":"Stiell","year":"2021","journal-title":"Canadian Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0002-8703(95)90324-0","article-title":"Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study","volume":"129","author":"Sung","year":"1995","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2011.10.108","article-title":"Vernakalant: conversion of atrial fibrillation in patients with ischemic heart disease","volume":"166","author":"Torp-Pedersen","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/hrt.2004.049171","article-title":"Amiodarone infusion in the treatment of acute atrial fibrillation or flutter: high versus low dose treatment","volume":"91","author":"Tuseth","year":"2005","journal-title":"Heart"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1067\/mhj.2000.107179","article-title":"Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study","volume":"140","author":"Villani","year":"2000","journal-title":"American Heart Journal"},{"issue":"17","key":"10.1002\/14651858.CD013255.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"1275-8","DOI":"10.1016\/0002-9149(89)90191-4","article-title":"Efficacy of intravenous propafenone for the acute management of atrial fibrillation","volume":"63","author":"Vita","year":"1989","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1378\/chest.105.4.1013","article-title":"Clinical course of recent-onset atrial fibrillation treated with oral propafenone","volume":"105","author":"Weiner","year":"1994","journal-title":"Chest"},{"issue":"62","key":"10.1002\/14651858.CD013255.pub2-BIB0204|cit204","first-page":"137","article-title":"[Comparison of efficacy, safety and cost-effectiveness of intravenous versus oral propafenone in paroxysmal atrial fibrillation]","volume":"11","author":"Zadura","year":"2001","journal-title":"Pol Merkur Lekarski"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0205|cit205","first-page":"188-90","article-title":"A comparative study on the efficacy and safety of intravenous amiodarone and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart falure","volume":"12","author":"Zhan","year":"2003","journal-title":"Journal of Emergency Medicine"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0206|cit206","first-page":"471","article-title":"Intravenous propafenone for conversion of atrial fibrillation in the emergency room [Hebrew]","volume":"143","author":"Antonelli","year":"2004","journal-title":"Harefuah"},{"issue":"1-2","key":"10.1002\/14651858.CD013255.pub2-BIB0207|cit207","first-page":"867","article-title":"Flecainide acetate vs digoxin in acute treatment of atrial fibrillation of recent onset: a randomized study","volume":"6","author":"Baldi","year":"1990","journal-title":"New Trends in Arrhythmias"},{"issue":"1-2","key":"10.1002\/14651858.CD013255.pub2-BIB0208|cit208","first-page":"499","article-title":"Propafenone vs flecainide in the acute treatment of atrial fibrillation of recent onset: a randomized study","volume":"8","author":"Baldi","year":"1992","journal-title":"New Trends in Arrhythmias"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013255.pub2-BIB0209|cit209","first-page":"141","article-title":"A randomized controlled study between placebo vs propafenone per os in a recent cardioversion of atrial fibrillation","volume":"23","author":"Botto","year":"1993","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013255.pub2-BIB0210|cit210","first-page":"271","article-title":"The efficacy of transthoracic electric cardioversion of the atrial fibrillation is not influenced by the position of the defriblillation platelets. A randomized controlled cross-over study","volume":"25","author":"Botto","year":"1995","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013255.pub2-BIB0211|cit211","first-page":"32","article-title":"Oral propafenone or digoxin in the treament of early atrial fibrillation cardioversion: a randomized study controlled with placebo","volume":"26","author":"Botto","year":"1996","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013255.pub2-BIB0212|cit212","first-page":"36","article-title":"Effect of fleicainide per os and amiodarione i.v. in the cardioversion of atrial fibrillation: a randomized study controlled with palcebo","volume":"21","author":"Capucci","year":"1991","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9149(92)91392-H","article-title":"Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension","volume":"70","author":"Capucci","year":"1992","journal-title":"American Journal of Cardiology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013255.pub2-BIB0214|cit214","first-page":"142","article-title":"Controlled clinical trial on the efficacy of propafenone or flecainide per os in the conversion of sinus rhythm of early atrial fibrillation","volume":"23","author":"Capucci","year":"1993","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0167-5273(94)90211-9","article-title":"A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm","volume":"43","author":"Capucci","year":"1994","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0167-5273(98)00363-5","article-title":"Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study","volume":"68","author":"Capucci","year":"1999","journal-title":"International Journal of Cardiology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013255.pub2-BIB0217|cit217","first-page":"32","article-title":"Oral propafenone in the conversion of atrial fibrillation. The multicentric study SATE","volume":"26","author":"Capucci","year":"1996","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0218|cit218","first-page":"481","article-title":"[Acute atrial fibrillation in the emergency room. Which is the best drug for a rapid sinus rhythm conversion?]","volume":"63","author":"Cesar","year":"1994","journal-title":"Arquivos Brasileiros de Cardiologia"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1536\/jhj.44.921","article-title":"External cardioversion in patients with persistent atrial fibrillation: a reappraisal of the effects of electrode pad position and transthoracic impedance on cardioversion success","volume":"44","author":"Chen","year":"2003","journal-title":"Japanese Heart Journal"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013255.pub2-BIB0220|cit220","first-page":"141","article-title":"Propafenone and flecainide in pharmacological acute conversion of the paroxistic atrial fibrillation","volume":"23","author":"Fera","year":"1993","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD013255.pub2-BIB0221|cit221","first-page":"84","article-title":"Comparative study of propafenone, amiodarone and flecainide in the treatment of paroxystic atrial fibrillation","volume":"51","author":"Martfnez","year":"1998","journal-title":"Revista Espanola de Cardiologia"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0222|cit222","first-page":"93","article-title":"Comparison with different sites of adhesive pad electrodes versus hand-held paddle electrodes for elective cardioversion of atrial fibrillation","volume":"na","author":"Forgione","year":"2000","journal-title":"New Trends in Electrocardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0223|cit223","first-page":"22","article-title":"[Comparison of the efficacy and safety of electrical cardioversion and pharmacological cardioversion with nibentan in patients with persisting atrial fibrillation and flutter]","volume":"5","author":"Giliarov","year":"2007","journal-title":"Vestnik Rossii\u0306skoi\u0306 Akademii Meditsinskikh Nauk"},{"issue":"8","key":"10.1002\/14651858.CD013255.pub2-BIB0224|cit224","first-page":"529","article-title":"Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias","volume":"43","author":"Joshi","year":"1995","journal-title":"Journal of the Association of Physicians in India"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD013255.pub2-BIB0225|cit225","first-page":"109","article-title":"[Sotalol and quinidine\/verapamil (Cordichin) in chronic atrial fibrillation - conversion and 12-month follow-up - a randomized comparison]","volume":"83","author":"Kalusche","year":"1994","journal-title":"Zeitschrift fu\u0308r Kardiologie"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0226|cit226","first-page":"477-90","article-title":"Clinical evaluation of intravenous cibenzoline in treatment of paroxysmal atrial fibrillation or paroxysmal atrial flutter. A multicenter double-blind study in comparison with placebo","volume":"19","author":"Kazuzo","year":"1991","journal-title":"Rinsho Hyoka (Clinical Evaluation)"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0227|cit227","first-page":"491-503","article-title":"Clinical effect of E0735 (flecainide) injection on paraxysmal atrial fibrillation\/flutter: a multicenter double-blind placebo-controlled comparative study","volume":"72","author":"Kazuzo","year":"1995","journal-title":"Rinsho to Kenkyu (Japanese Journal of Clinical and Experimental Medicine)"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0228|cit228","first-page":"265","article-title":"Comparison the effectiveness of damped sine wave monophasic and rectilinear biphasic shocks in patients with persistent atrial fibrillation [Czech]","volume":"15","author":"Kmec","year":"2006","journal-title":"Kardiologia"},{"issue":"17","key":"10.1002\/14651858.CD013255.pub2-BIB0229|cit229","first-page":"510","article-title":"Comparative evaluation of verapamil, flecainide and propafenone for the acute conversion of atrial fibrillation to sinus rhythm","volume":"102","author":"Kondili","year":"1990","journal-title":"Wiener klinische Wochenschrift"},{"issue":"9 Suppl A","key":"10.1002\/14651858.CD013255.pub2-BIB0230|cit230","article-title":"Pad type and manual pressure augmentation with maximum output shocks in atrial fibrillation cardioversion: a randomized controlled trial (PRESS-AF STUDY)","volume":"79","author":"Lakananurak","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.gheart.2014.03.1430","article-title":"Vernakalant versus flecainide and propafenone in acute atrial fibrillation","volume":"1","author":"Lalor","year":"2014","journal-title":"Global Heart"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0232|cit232","first-page":"207","article-title":"[Comparison of amiodarone and quinidine in the conversion to sinusal rhythm of atrial fibrillation of recent onset]","volume":"20","author":"Negrini","year":"1990","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0233|cit233","first-page":"121","article-title":"[Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study]","volume":"86","author":"Niu","year":"2006","journal-title":"Chung Hua I Hsueh Tsa Chih"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0234|cit234","first-page":"141","article-title":"Propafenone versus quinidine in recent onset atrial fibrillation [Italian]","volume":"44","author":"Satullo","year":"1996","journal-title":"Minerva Cardioangiologica"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0235|cit235","first-page":"175","article-title":"Pharmacological conversion of recent onset atrial fibrillation: a randomized study of propafenone and amiodarone","volume":"2","author":"Taha","year":"2013","journal-title":"Cardiology (Switzerland)"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0236|cit236","first-page":"ii273","article-title":"Comparison of the efficacy and safety of injectable propafenone and amiodarone for elimination of paroxysmal atrial fibrillation in patients without organic heart disease","volume":"21","author":"Tarasov","year":"2019","journal-title":"Europace"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0237|cit237","first-page":"293","article-title":"Propafenone compared with amiodarone for conversion to sinus rhythm of recent onset atrial fibrillation [Italian]","volume":"42","author":"Treglia","year":"1994","journal-title":"Minerva Cardioangiologica"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0238|cit238","first-page":"408","article-title":"Comparison of a single oral dose of propafenone with a single intravenous dose of amiodarone in converting paroxysmal atrial fibrillation [Greek]","volume":"40","author":"Tsaknakis","year":"1999","journal-title":"Hellenic Journal of Cardiology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013255.pub2-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/cc3572","article-title":"Comparison of monophasic versus biphasic cardioversion for atrial fibrillation","volume":"9","author":"Vaisman","year":"2005","journal-title":"Critical Care (London, England)"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/B:CEPR.0000012400.34597.00","article-title":"Amiodarone for the restoration of sinus rhythm in patients with atrial fibrillation","volume":"7","author":"Vardas","year":"2003","journal-title":"Cardiac Electrophysiology Review"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0241|cit241","first-page":"564","article-title":"[The efficacy of oral treatment with flecainide for paroxysmal atrial fibrillation: correlation with plasma concentration]","volume":"20","author":"Villani","year":"1990","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013255.pub2-BIB0242|cit242","first-page":"1","article-title":"Comparison of converting therapy between ibutilide and propafenone in Chinese patients with atrial fibrillation and atrial flutter","volume":"129","author":"Wu","year":"2014","journal-title":"Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD013255.pub2-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1368-5031.2005.00705.x","article-title":"Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation","volume":"59","author":"Zhang","year":"2005","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0244|cit244","unstructured":"Effect of different discharge energy on the efficacy of transthoracic cardioversion in patients with persistent atrial fibrillation https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR1900024500"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0245|cit245","unstructured":"A phase 3, randomized, double-blind, placebo-controlled trial of flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm - RESTORE-1 https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2021-001627-40-CZ"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0246|cit246","unstructured":"RAFF4 Trial: vernakalant vs. procainamide for acute atrial fibrillation in the emergency department https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04485195"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0247|cit247","unstructured":"Oral amiodarone for acute cardioversion of atrial fibrillation study (AAA) https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04594746?term=NCT04594746&draw=2&rank=1"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0248|cit248","unstructured":"A study of IV HBI-3000 for the conversion recent onset atrial fibrillation (AF) https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04680026?term=NCT04680026&draw=2&rank=1"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0249|cit249","unstructured":"Comparison of two DCCV algorithms - rational versus maximum fixed energy (PROTOCOLENERGY) https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05148923?term=NCT05148923&draw=2&rank=1"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0250|cit250","unstructured":"Anteroposterior versus anterolateral electrode position for electrical cardioversion of atrial fibrillation (SHOCK-VECTOR) https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05511389?term=NCT05511389&draw=2&rank=1"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0251|cit251","unstructured":"Flecainide versus amiodarone in the cardioversion of paroxysmal atrial fibrillation at the emergency department, in patients with coronary artery disease without residual ischemia (FLECA-ED) https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05549752"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0252|cit252","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Joglar","year":"2023","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cjca.2018.08.026","article-title":"Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation","volume":"34","author":"Andrade","year":"2018","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0255|cit255","volume-title":"Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease","year":"2012"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0256|cit256","unstructured":"Arunachalam K Alzahrani T Flecainide In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing"},{"issue":"10","key":"10.1002\/14651858.CD013255.pub2-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0258|cit258","first-page":"41A","article-title":"Hospitalisation of arrhythmias in the United States: importance of atrial fibrillation","volume":"19","author":"Bialy","year":"1992","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/STROKEAHA.113.002329","article-title":"Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study","volume":"44","author":"Bj\u00f6rck","year":"2013","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1023\/B:CEPR.0000023140.38226.75","article-title":"AFFIRM and RACE trials: implications for the management of atrial fibrillation","volume":"7","author":"Blackshear","year":"2003","journal-title":"Cardiac Electrophysiology Review"},{"issue":"24","key":"10.1002\/14651858.CD013255.pub2-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.2165\/00003495-200464240-00003","article-title":"Pharmacological cardioversion of atrial fibrillation: current management and treatment options","volume":"64","author":"Boriani","year":"2004","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"Journal of Clinical Epidemiology"},{"issue":"16","key":"10.1002\/14651858.CD013255.pub2-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.109.865535","article-title":"Cardioversion: past, present, and future","volume":"120","author":"Cakulev","year":"2010","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0264|cit264","first-page":"897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence as well","volume":"331","author":"Caldwell","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jacc.2010.07.046","article-title":"A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation","volume":"57","author":"Camm","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"1489-96","DOI":"10.1007\/s00296-014-2994-2","article-title":"Network meta-analysis for comparing treatment effects of multiple interventions: an introduction","volume":"34","author":"Catala-Lopez","year":"2014","journal-title":"Rheumatology International"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.84.2.913","article-title":"Mechanism of cardiac defibrillation. A different point of view","volume":"84","author":"Chen","year":"1991","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"130-7","DOI":"10.7326\/0003-4819-159-2-201307160-00008","article-title":"Conceptual and technical challenges in network meta-analysis","volume":"159","author":"Cipriani","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0270|cit270","unstructured":"The Cochrane Collaboration CRS (Cochrane Register of Studies) community.cochrane.org\/tools\/data-management-tools\/crs"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0271|cit271","unstructured":"Reporting the effects of an intervention in EPOC reviews EPOC Resources for review authors; available at epoc.cochrane.org\/resources\/epoc-resources- review-authors"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.109.875252","article-title":"Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation\/atrial flutter","volume":"120","author":"Connolly","year":"2009","journal-title":"Circulation"},{"issue":"24","key":"10.1002\/14651858.CD013255.pub2-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0274|cit274","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003713.pub2","article-title":"Pharmacological cardioversion for atrial fibrillation and flutter","author":"Cordina","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0275|cit275","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003713.pub3","article-title":"Pharmacological cardioversion for atrial fibrillation and flutter","author":"Cordina","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD013255.pub2-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study","volume":"109","author":"Corley","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0277|cit277","unstructured":"Covidence Vertitas Health Innovation Ltd"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0278|cit278","first-page":"903","article-title":"Factors determining success and energy requirements for cardioversion of atrial fibrillation","volume":"76","author":"Dalzell","year":"1990","journal-title":"Quarterly Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/europace\/euaa024","article-title":"Pharmacologic cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis","volume":"22","author":"DeSouza","year":"2020","journal-title":"Europace"},{"issue":"14","key":"10.1002\/14651858.CD013255.pub2-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.amjcard.2019.12.041","article-title":"Use of flecainide for the treatment of atrial fibrillation","volume":"125","author":"Echt","year":"2020","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0282|cit282","unstructured":"European Medicines Agency Note for guidance on choice of control group in clinical trials (CPMP\/ICH\/364\/96) https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e-10-choice-control-group-clinical-trials-step-5_en.pdf"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0284|cit284","first-page":"ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"ehaa612","author":"Hindricks","year":"2020","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0285|cit285","unstructured":"FDA Drug Safety Communication: Review update of Multaq (dronedarone) and increased risk of death and serious cardiovascular adverse events www.fda.gov\/Drugs\/DrugSafety\/ucm283933.htm"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.CIR.86.4.1233","article-title":"Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques","volume":"86","author":"Feld","year":"1992","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","article-title":"Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries","volume":"37","author":"Friberg","year":"2016","journal-title":"European Heart Journal"},{"issue":"18","key":"10.1002\/14651858.CD013255.pub2-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0289|cit289","first-page":"1361","article-title":"Drugs for arrhythmias","volume":"90","author":"Gunton","year":"1964","journal-title":"Canadian Medical Association Journal"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"e001486","DOI":"10.1161\/JAHA.114.001486","article-title":"Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation","volume":"4","author":"Haim","year":"2015","journal-title":"Journal of the American Heart Association"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"70","DOI":"10.15420\/aer.2018.71.2","article-title":"Introducing vernakalant into clinical practice","volume":"8","author":"Hall","year":"2019","journal-title":"Arrhythmia Electrophysiology Review"},{"issue":"10","key":"10.1002\/14651858.CD013255.pub2-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Ha\u00efssaguerre","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0293|cit293","unstructured":"List of Clinical Registries available on the US Department of Health and Human Services www.hhs.gov\/ohrp\/international\/clinical-trial-registries\/index.html"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0294|cit294","first-page":"2733-49","article-title":"Borrowing strength from external trials in a meta-analysis","volume":"15","author":"Higgins","journal-title":"Statistics in Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0297|cit297","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD013255.pub2-BIB0298|cit298","doi-asserted-by":"publisher","first-page":"98\u2013110","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0299|cit299","volume-title":"Methodological Expectations of Cochrane Intervention Reviews","author":"Higgins","year":"2016"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0300|cit300","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"issue":"7","key":"10.1002\/14651858.CD013255.pub2-BIB0301|cit301","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ije\/dyu115","article-title":"Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies","volume":"43","author":"Hro\u0301bjartsson","year":"2014","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.resuscitation.2015.12.009","article-title":"Monophasic and biphasic shock for transthoracic conversion of atrial fibrillation: systematic review and network meta-analysis","volume":"100","author":"In\u00e1cio","year":"2016","journal-title":"Resuscitation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0304|cit304","unstructured":"ISRCTN www.isrctn.com"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0305|cit305","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.111.019893","article-title":"Atrial fibrillation pathophysiology implications for management","volume":"124","author":"Iwasaki","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jrsm.1188","article-title":"The design-by-treatment interaction model: a unifying framework for modelling loop inconsistency in network meta-analysis","volume":"7","author":"Jackson","year":"2015","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(02)11315-8","article-title":"Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial","volume":"360","author":"Kirchhof","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0308|cit308","unstructured":"Knight BP Cardioversion (Beyond the Basics) www.uptodate.com\/contents\/cardioversion-beyond-the-basics"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0309|cit309","unstructured":"Knight BP Patient education: cardioversion (Beyond the Basics) www.uptodate.com\/contents\/cardioversion-beyond-the-basics"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0310|cit310","first-page":"13","article-title":"Vernakalant in atrial fibrillation: a relatively new weapon in the armamentarium against an old enemy","volume":"3","author":"Kossaify","year":"2019","journal-title":"Drug Target Insights"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0312|cit312","doi-asserted-by":"crossref","first-page":"5414\u201329","DOI":"10.1002\/sim.6001","article-title":"Visualizing the flow of evidence in network meta-analysis and characterizing mixed treatment comparisons","volume":"32","author":"K\u00f6nig","year":"2013","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1056\/NEJMe078110","article-title":"Clinical trial registration - looking back and moving ahead","volume":"356","author":"Laine","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD013255.pub2-BIB0314|cit314","doi-asserted-by":"publisher","first-page":"352S","DOI":"10.1161\/01.CIR.94.7.1613","article-title":"Antithrombotic therapy in atrial fibrillation","volume":"108","author":"Laupacis","year":"1995","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8167.2010.01764.x","article-title":"A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study","volume":"21","author":"Le Heuzey","year":"2012","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0316|cit316","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0317|cit317","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0318|cit318","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0319|cit319","first-page":"548","article-title":"New method for terminating cardiac arrhythmias: use of synchronized capacitor discharge","volume":"182","author":"Lown","year":"1962","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0320|cit320","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM196308152690701","article-title":"\u201cCardioversion\u201d of atrial fibrillation: a report on the treatment of 65 episodes in 50 patients","volume":"269","author":"Lown","year":"1963","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0321|cit321","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"Journal of American Statistical Association"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0322|cit322","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.CIR.86.5.1415","article-title":"A randomized comparison of external and internal cardioversion of chronic atrial fibrillation","volume":"86","author":"L\u00e9vy","year":"1992","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD013255.pub2-BIB0323|cit323","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/FJC.0000000000000832","article-title":"Systematic review and meta-analysis appraising efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation","volume":"76","author":"Ma","year":"2020","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-59745-163-5_2","volume-title":"Atrial Fibrillation from Bench to Bedside","author":"Maddox","year":"2008"},{"issue":"18","key":"10.1002\/14651858.CD013255.pub2-BIB0325|cit325","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.111.039677","article-title":"Atrial fibrillation: current knowledge and future directions in epidemiology and genomics","volume":"124","author":"Magnani","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0326|cit326","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jemermed.2017.11.016","article-title":"Intravenous flecainide for emergency department management of acute atrial fibrillation","volume":"54","author":"Markey","year":"2018","journal-title":"Journal of Emergency Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013255.pub2-BIB0327|cit327","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD013255.pub2-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/europace\/euz175","article-title":"Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis","volume":"21","author":"McIntyre","year":"2019","journal-title":"Europace"},{"issue":"3","key":"10.1002\/14651858.CD013255.pub2-BIB0329|cit329","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002903.pub2","article-title":"Electrical cardioversion for atrial fibrillation and flutter","author":"Mead","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD013255.pub2-BIB0330|cit330","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002903.pub3","article-title":"Electrical cardioversion for atrial fibrillation and flutter","author":"Mead","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/2012.jama.11228","article-title":"How to use an article reporting a multiple treatment comparison meta-analysis","volume":"308","author":"Mills","year":"2012","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)","volume":"35","author":"Mont","year":"2014","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0334|cit334","unstructured":"QOL improvement after cardioversion of persistent AF (QOL-CAFRCT) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05136131"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0335|cit335","unstructured":"R\u00fccker G Schwarzer G Krahn U K\u00f6nig J Network meta-analysis using frequentist methods cran.r-project.org\/web\/packages\/netmeta\/netmeta.pdf"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0336|cit336","doi-asserted-by":"crossref","first-page":"e115065","DOI":"10.1371\/journal.pone.0115065","article-title":"Network meta-analysis using R: a review of currently available automated packages","volume":"9","author":"Neupane","year":"2014","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0337|cit337","unstructured":"National Institute for Health and Clinical Excellence Review of TA197: Dronedarone for the treatment of non-permanent atrial fibrillation www.nice.org.uk\/guidance\/ta197\/documents\/appendix-b-proposal-paper-presented-to-the-institutes-guidance-executive2"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0338|cit338","unstructured":"National Institute for Health and Clinical Excellence (NICE) Atrial fibrillation: management. NICE guidelines [CG180] nice.org.uk\/guidance\/cg180"},{"issue":"12","key":"10.1002\/14651858.CD013255.pub2-BIB0339|cit339","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.jacc.2005.03.020","article-title":"Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study","volume":"45","author":"Olshansky","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0340|cit340","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/hc0902.104712","article-title":"Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation","volume":"105","author":"Oral","year":"2002","journal-title":"Circulation"},{"issue":"13","key":"10.1002\/14651858.CD013255.pub2-BIB0341|cit341","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693.","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0342|cit342","first-page":"525","article-title":"Post ablation left atrial tachycardia: understanding mechanism, prevention and treatment","volume":"5","author":"Pappone","year":"2012","journal-title":"Journal of Atrial Fibrillation"},{"issue":"24","key":"10.1002\/14651858.CD013255.pub2-BIB0343|cit343","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.jacc.2015.10.036","article-title":"Design of major randomized trials: part 3 of a 4-part series on statistics for clinical trials","volume":"66","author":"Pocock","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0345|cit345","unstructured":"R: A language and environment for statistical computing R Foundation for Statistical Computing 2017"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0346|cit346","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/hrt.30.6.786","article-title":"Appraisal of electroconversion in treatment of cardiac dysrhythmias","volume":"30","author":"Resnekov","year":"1968","journal-title":"British Heart Journal"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0347|cit347","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2023"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0348|cit348","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2217\/fca-2020-0039","article-title":"Vernakalant hydrochloride for the treatment of atrial fibrillation: evaluation of its place in clinical practice","volume":"16","author":"Ritchie","year":"2020","journal-title":"Future Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0349|cit349","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/jrsm.1058","article-title":"Network meta-analysis, electrical networks and graph theory","volume":"3","author":"R\u00fccker","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0350|cit350","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0351|cit351","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jclinepi.2008.10.001","article-title":"A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered","volume":"62","author":"Salanti","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0352|cit352","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.annemergmed.2010.09.027","article-title":"Emergency department management and 1-year outcomes of patients with atrial flutter","volume":"57","author":"Scheuermeyer","year":"2011","journal-title":"Annals of Emergency Medicine"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0353|cit353","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-21416-0","volume-title":"Meta-Analysis with R","author":"Schwarzer","year":"2015"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0354|cit354","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0140-6736(06)68708-4","article-title":"Clinical trial registration: transparency is the watchword","volume":"367","author":"Sim","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0355|cit355","unstructured":"Same authors of this Network Meta-Analysis Supplementary Table 1 - Adverse Effects or Complications available online at FigShare: https:\/\/dx.doi.org\/10.6084\/m9.figshare.20179154 2022"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0356|cit356","unstructured":"Szymanski MW Cassagnol M Ibutilide In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0357|cit357","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1378\/chest.101.1.34","article-title":"The alternation between atrial flutter and atrial fibrillation","volume":"101","author":"Tunick","year":"1992","journal-title":"Chest"},{"issue":"23","key":"10.1002\/14651858.CD013255.pub2-BIB0358|cit358","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013255.pub2-BIB0359|cit359","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/j.1552-4604.1984.tb01822.x","article-title":"A classification of antiarrhythmic actions reassessed after a decade of new drugs","volume":"24","author":"Vaughan Williams","year":"1984","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0360|cit360","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","article-title":"Approaches to catheter ablation for persistent atrial fibrillation","volume":"372","author":"Verma","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD013255.pub2-BIB0361|cit361","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/hrt.79.6.568","article-title":"Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation","volume":"79","author":"Vos","year":"1998","journal-title":"Heart"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0362|cit362","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.1923.02650060042012","article-title":"Cinchona derivates in the treatment of heart disorders","volume":"81","author":"Wenckbach","year":"1923","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0363|cit363","unstructured":"World Health Organization International Clinical Trials Registry Platform www.who.int\/ictrp\/en"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0364|cit364","unstructured":"World Health Organization International standards for Clinical Trial Registries apps.who.int\/iris\/bitstream\/10665\/76705\/1\/9789241504294_eng.pdf?ua=1&ua=1"},{"issue":"10","key":"10.1002\/14651858.CD013255.pub2-BIB0365|cit365","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"issue":"23","key":"10.1002\/14651858.CD013255.pub2-BIB0366|cit366","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013255.pub2-BIB0367|cit367","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.04.018","article-title":"Development of the summary of findings table for network meta-analysis","volume":"115","author":"Yepes-Nu\u00f1ez","year":"2019","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:22:53Z","timestamp":1761571373000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013255.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":367,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013255.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]}}}